PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Simon Tiberi

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; GSK Global Health, London, UK.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

JOURNAL ARTICLE

Advances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines.

The Lancet. Microbe

A comprehensive narrative review synthesizing pivotal trial evidence and WHO guideline updates on tuberculosis treatment innovation since 2020, without reporting new primary efficacy data.

Expert GuidanceBen J Marais Simon Tiberi Delia Goletti

Reported

Estimated tuberculosis incidence…10.7 million

Estimated tuberculosis deaths glo…1.23 million

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support